<DOC>
	<DOCNO>NCT01171235</DOCNO>
	<brief_summary>The aim study find one serum tissue marker molecular biology head neck cancer patient use early diagnosis , predict prognosis sensitive chemotherapy radiotherapy</brief_summary>
	<brief_title>Study Biomarker From Blood Tissue Head Neck Carcinoma</brief_title>
	<detailed_description>Head neck malignant tumor , especially nasopharyngeal carcinoma southern China high incidence , incidence , treatment , prognosis tumor marker serum hot research little progress.In study , collect NPC-based collection include blood sample laryngeal , hypopharyngeal cancer , separate serum white blood cell store -80 degrees，while tissue freeze liquid nitrogen embed paraffin。 Patient treatment prognosis combine order find marker molecular biology use early diagnosis , predict prognosis sensitive chemotherapy radiotherapy .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Laryngeal Neoplasms</mesh_term>
	<mesh_term>Pharyngeal Neoplasms</mesh_term>
	<criteria>nasopharyngeal carcinoma hypopharyngeal carcinoma laryngeal carcinoma visit ENT department NanFang hospital patient whose anticipated survival duration le 6 month</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Laryngeal Neoplasms</keyword>
	<keyword>Pharyngeal Neoplasms</keyword>
</DOC>